Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder (NCT07734103)
A Single-Center, Double-Blind, Placebo-Controlled, Study to Evaluate Lumateperone, Flexible Doses of 21mg or 42mg in Patients With Moderate to Severe Childhood Onset Fluency Disorder, Stuttering.
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the efficacy and tolerability of Lumateperone in reducing stuttering symptoms. The following scales and samples will be collected for clinical and functional outcomes. • MLGSSS • SSS • Stuttering Severity Instrument (SSI-IV) • PHQ-9 • Barnes Akathisia • SAS • AIMS • CGI-I • CGI-S
Who can join: Review the eligibility criteria below.
Location: CSTrials — Costa Mesa, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- CSTrials — Costa Mesa, California
📞 Contact the Study Coordinator
Phone: (714) 900-3969
Email: Tommy@CSTrials.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Stuttering, Adult
- Effects of Altered Auditory Feedback on Speech Fluency — Cambridge, Massachusetts
- Dopamine and Sensorimotor Function in Stuttering — San Francisco, California
- Transcranial Alternating Current Stimulation (tACS) in Stuttering — Ann Arbor, Michigan
- Using Transcranial Magnetic Stimulation to Treat Stuttering — Manhattan, Kansas
Explore by condition: All Stuttering, Adult clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.